Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa

Sexually Transmitted Diseases

Volumn 33, Issue 11, 2006, Pages 683-687

  Myer, Landon ^a,b   Wright, Thomas C ^c   Denny, Lynette ^a   Kuhn, Louise ^b,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Columbia University ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; CANCER SCREENING; CHLAMYDIASIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; SEROCONVERSION; SOUTH AFRICA; SPECULAR MICROSCOPY; TRICHOMONIASIS; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; UTERINE CERVIX MUCUS;

ADULT; AGED; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MIDDLE AGED; MUCOUS MEMBRANE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS;

EID: 33750291458     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000216026.67352.f9     Document Type: Article

References (36)

1. Davis CW, Doms RW. HIV transmission: closing all the doors. J Exp Med 2004; 199:1037-1040.
2. Rustomjee R, Abdool Karim Q, Abdool Karim SS, Laga M, Stein Z. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS 1999; 13:1511-1515.
3. Weir SS, Roddy RE, Zekeng L, Feldblum PJ. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Genitourin Med 1995; 71:78-81.
4. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 2002; 360:971-977.
5. Mauck CK, Baker JM, Birnkrant DB, Rowe PJ, Gabelnick HL. The use of colposcopy in assessing vaginal irritation in research. AIDS 2000; 14:2221-2227.
6. Reynolds SJ, Quinn TC. Developments in STD/HIV interactions: The intertwining epidemics of HIV and HSV-2. Infect Dis Clin North Am 2005; 19:415-425.
7. van de Wijgert JH, Chirenje ZM, Iliff V, et al. Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women. J Acquir Immun Defic Syndr 2000; 24:62-67.
8. Myer L, Denny L, De Souza M, Wright TC, Kuhn L. Distinguishing the temporal association between women's intravaginal practices and risk of HIV infection: A prospective study among South African women. Am J Epidemiol 2006; 163:552-560.
9. Myer L, Kuhn L, Stein ZA, Wright TC, Denny L. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: Epidemiological evidence and biological mechanisms. Lancet Infect Dis 2005; 5:786-794.
10. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-174.
11. Pudney J, Wang YM, Mackay CR, Anderson D. Expression of chemokine receptors in human reproductive tissues [Abstract #49]. Meetings of the Society for Gynecological Investigation, San Diego, 1997.
12. Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286:1353-1357.
13. Hirsch M. Herpes simplex virus. In: Madell GL DR, Bennett JE, eds. Principles and Practice of Infectious Disease. New York: Churchill Livingstone, 1990:1144-1152.
14. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK SP, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999:407-422.
15. Hook EW, Hansfield HH. Gonococcal infections in the adult. In: Holmes KK SP, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1998:451-466.
16. Plourde PJ, Pepin J, Agoki E, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994; 170:313-317.
17. Nicolosi A, Correa LML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology 1994; 5:570-575.
18. Moss GB, Clemetson D, D'Costa L, et al. Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: Results of a study of couples in Nairobi, Kenya. J Infect Dis 1991; 164:588-591.
19. Mati JK, Hunter DJ, Maggwa BN, Tukei PM. Contraceptive use and the risk of HIV infection in Nairobi, Kenya. Int J Gynaecol Obstet 1995; 48:61-67.
20. Moscicki AB, Ma Y, Holland C, Vermund SH. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis 2001; 183:865-870.
21. Plourde PJ, Pepin J, Agoki E, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994; 170:313-317.
22. Jacobson DL, Peralta L, Graham NM, Zenilman J. Histologic development of cervical ectopy: Relationship to reproductive hormones. Sex Transm Dis 2000; 27:252-258.
23. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173:534-543.
24. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial. JAMA 2005; 294:2173-2181.
25. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
26. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992; 135:1042-1050.
27. Myer L, Denny L, Telerant R, De Souza M, Wright TC, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection among South African women: A nested case-control study. J Infect Dis 2005; 192:1372-1380.
28. CONRAD. Manual for the Standardization of Colposcopy for the Evaluation of Vaginal Products: Update 2000. Arlington and Geneva: CONRAD and WHO, 2000.
29. Bollen L, Kilmarx P, Wiwatwongwana P. Photo Atlas for Microbicide Evaluation. Bangkok, Thailand: Thailand MOPH-US CDC Collaboration, 2002.
30. Kuhn L, Denny L, Pollack AE, Wright TC. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception 1999; 59:363-367.
31. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modelling of Time-to-Event Data. New York: Wiley and Sons, 1999.
32. Wacholder S, Gail M, Pee D. Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort. Biometrics 1991; 47:63-76.
33. Brown RC, Brown JE, Ayowa OB. The use and physical effects of intravaginal substances in Zairian women. Sex Transm Dis 1993; 20:96-99.
34. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: A prospective study. Lancet 2005; 366:1182-1188.
35. Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: The unexplored promise of internal vaginal barrier devices. AIDS 2001; 15:1595-1602.
36. Minnis AM, Padian NS. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: Current evidence and future research directions. Sex Transm Infect 2005; 81:193-200.